Biomedical Sciences (BMS) Graduate Program, University of California, San Francisco, CA, USA.
Division of Rheumatology, Department of Medicine, Rosalind Russell and Ephraim P. Engleman Arthritis Research Center, University of California, San Francisco, CA, USA.
Immunol Rev. 2019 Nov;292(1):37-60. doi: 10.1111/imr.12818. Epub 2019 Oct 20.
Efficient mechanisms of central tolerance, including receptor editing and deletion, prevent highly self-reactive B cell receptors (BCRs) from populating the periphery. Despite this, modest self-reactivity persists in (and may even be actively selected into) the mature B cell repertoire. In this review, we discuss new insights into mechanisms of peripheral B cell tolerance that restrain mature B cells from mounting inappropriate responses to endogenous antigens, and place recent work into historical context. In particular, we discuss new findings that have arisen from application of a novel in vivo reporter of BCR signaling, Nur77-eGFP, expression of which scales with the degree of self-reactivity in both monoclonal and polyclonal B cell repertoires. We discuss new and historical evidence that self-reactivity is not just tolerated, but actively selected into the peripheral repertoire. We review recent progress in understanding how dual expression of the IgM and IgD BCR isotypes on mature naive follicular B cells tunes responsiveness to endogenous antigen recognition, and discuss how this may be integrated with other features of clonal anergy. Finally, we discuss how expression of Nur77 itself couples chronic antigen stimulation with B cell tolerance.
有效的中枢耐受机制,包括受体编辑和删除,可防止高自身反应性 B 细胞受体 (BCR) 在外周组织中存在。尽管如此,适度的自身反应性仍存在于(甚至可能被积极选择进入)成熟 B 细胞库中。在这篇综述中,我们讨论了外周 B 细胞耐受机制的新见解,这些机制限制了成熟 B 细胞对内源性抗原产生不适当的反应,并将最近的工作置于历史背景下。特别是,我们讨论了从新型 BCR 信号体内报告基因 Nur77-eGFP 的应用中得出的新发现,该报告基因的表达与单克隆和多克隆 B 细胞库中的自身反应性程度成正比。我们讨论了新的和历史的证据,表明自身反应性不仅被容忍,而且被积极选择进入外周库。我们综述了最近在理解成熟幼稚滤泡 B 细胞上 IgM 和 IgD BCR 同种型的双重表达如何调节对内源性抗原识别的反应性方面的进展,并讨论了这如何与克隆无能的其他特征相结合。最后,我们讨论了 Nur77 本身的表达如何将慢性抗原刺激与 B 细胞耐受联系起来。